These novel medications , Tirzepatide , represent a significant advancement in treating metabolic dysfunction and potentially associated conditions . These drugs are categorized as GLP-1 pathway https://diegoakrk785016.bloggactivo.com/40403967/tirzepatide-a-thorough-dive-into-incretin-agents